跳至主要内容
临床试验/JPRN-UMIN000029945
JPRN-UMIN000029945尚未招募1 期

Phase I/II trial of AM01 (amnion-derived mesenchymal stem cells) for steroid-refractory acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation - Phase I/II trial of AM01 (amnion-derived mesenchymal stem cells) for steroid-refractory acute GVHD

Hyogo College of Medicine0 个研究点目标入组 12 人开始时间: 2017年11月13日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Has received more than one treatment for acute GVHD other than steroid 2. Presence of liver dysfunction other than GVHD (serum total bilirubin >2.0mg/dl or serum AST/ALT >3 times upper limit of normal) 3. Presence of kidney dysfunction (serum creatinine >2.0mg/dl) 4. Percutaneous oxygen saturation is less than 94% even under oxygen administration 5. Presence of an uncontrolled severe infection 6. Presence of severe hypersensitivity to bovine-derived constituents, human serum albumin and gentamicin 7. History of hypersensitivity to iodine or iodine-containing contrast agent 8. Previous participation in a study of any treatment with cell therapy product 9. Previous participation in a study of any investigational treatment within 12 weeks of agreement for this study 10. In pregnancy or breast-feeding 11. Considered as ineligible to this study

研究者

相似试验

Phase I/II trial of AM01 (amnion-derived mesenchymal... | 临床试验